BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8547469)

  • 1. Gonadotropin-releasing hormone agonist suppression of ovarian tumorigenesis in mice of the Wx/Wv genotype.
    Blaakaer J; Baeksted M; Micic S; Albrectsen P; Rygaard J; Bock J
    Biol Reprod; 1995 Oct; 53(4):775-9. PubMed ID: 8547469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin uptake in genetic and irradiation models of ovarian tumorigenesis.
    Beamer WG; Tennent BJ
    Biol Reprod; 1986 May; 34(4):761-70. PubMed ID: 3085740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women.
    Filicori M; Flamigni C; Cognigni G; Dellai P; Arnone R; Falbo A; Capelli M
    J Clin Endocrinol Metab; 1993 Jul; 77(1):130-3. PubMed ID: 8325935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells.
    Choi JH; Choi KC; Auersperg N; Leung PC
    Endocr Relat Cancer; 2006 Jun; 13(2):641-51. PubMed ID: 16728589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma gonadotropin levels during early stages of ovarian tumorigenesis in mice of the W x -W u genotype.
    Murphy ED; Beamer WG
    Cancer Res; 1973 Apr; 33(4):721-3. PubMed ID: 4696472
    [No Abstract]   [Full Text] [Related]  

  • 6. Ovarian tumors not induced by irradiation and gonadotropins in hypogonadal (hpg) mice.
    Tennent BJ; Beamer WG
    Biol Reprod; 1986 May; 34(4):751-60. PubMed ID: 3708055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel peptides in ovarian follicular fluid: implications for contraceptive development.
    Schwartz NB
    Res Front Fertil Regul; 1982 Sep; 2(2):1-11. PubMed ID: 12179632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alleles at the W locus on testicular luteinizing hormone receptors in adult mice.
    Amador A; Parkening T; Beamer W; Bartke A; Collins TJ
    J Recept Res; 1984; 4(7):741-53. PubMed ID: 6098681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the effects of gonadotropin-releasing hormone analogues in the inhibition of ovarian cancer transplanted tumors and in the protection of ovarian function after chemotherapy on nude mice].
    Zhang Y; Lu ZY; Yan XH; Wang JJ; Feng WW; Ding JX; Hua Kq
    Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):892-7. PubMed ID: 22333277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone feedback on gonadotropin secretion and gene expression in transgenic mice expressing human growth hormone gene.
    Tang K; Bartke A; Gardiner CS; Wagner TE; Yun JS
    J Androl; 1994; 15(1):9-14. PubMed ID: 8188541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
    Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of Rev7 function results in development of tubulostromal adenomas in mouse ovary.
    Abbasi A; Khalaj M; Akiyama K; Mukai Y; Matsumoto H; Acosta TJ; Said N; Yoshida M; Kunieda T
    Mol Cell Endocrinol; 2015 Sep; 412():19-25. PubMed ID: 26004212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist.
    Ward JA; Robinson J; Furr BJ; Shalet SM; Morris ID
    Cancer Res; 1990 Feb; 50(3):568-74. PubMed ID: 2137024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both in vivo FSH depletion and follicular exposure to Gonadotrophin-releasing hormone analogues in vitro are not effective to prevent follicular depletion during chemotherapy in mice.
    Horicks F; Van Den Steen G; Gervy C; Clarke HJ; Demeestere I
    Mol Hum Reprod; 2018 Apr; 24(4):221-232. PubMed ID: 29438534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART.
    Sonntag B; Kiesel L; Nieschlag E; Behre HM
    J Assist Reprod Genet; 2005 Aug; 22(7-8):277-83. PubMed ID: 16195824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active immunization of gilts against gonadotropin-releasing hormone: effects on secretion of gonadotropins, reproductive function, and responses to agonists of gonadotropin-releasing hormone.
    Esbenshade KL; Britt JH
    Biol Reprod; 1985 Oct; 33(3):569-77. PubMed ID: 2932169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.